CBX5 and myeloid sarcoma: Similar to the monocytes, the remaining PBMCs from Lo-CBX5 MS patients displayed the reduced expression of CBX5, INTS3, and INTS8 compared with the remaining PBMCs from SC and Hi-CBX5 patients (Fig S3B).